Benesch is representing real estate investment trust HCP Inc., as health care regulatory counsel, in connection with its planned spinoff of certain assets into a separate and independent REIT.
The Irvine, California-based firm is planning to spin off HCR ManorCare, which comprises a portfolio of assisted living and skilled nursing facilities, into an independent public REIT.
The company said that the spinoff will help it focus on core areas of the company such as medical office properties, senior housing and life sciences properties. Following the spinoff, HCP expects its portfolio to have more than 860 properties and generate $1.4 billion in annual income.
The Benesch team was led by Alan Schabes.
Latest News
Law360 Highlights Benesch’s Continued Success Defeating Fake Price Markdown Class Actions
Law360 Pulse recently spotlighted Benesch’s latest appellate victory for retailers, detailing how the firm successfully defeated proposed class action claims …
Partner Vince Nardone Quoted in Mergermarket on Why Dental Deals Are Getting Harder to Close
Vince Nardone, co-chair of the firm’s Dental/DSO Industry Team, was recently quoted by Mergermarket in an article titled “Pulling teeth: Why dental deals are getting harder to close – Dealspeak North America.”
LiveNOW from FOX Interviews Kevin Frankel on Charges Against U.S. Soldier Tied to $400K Polymarket Bet
Kevin Frankel, chair of Benesch’s State Attorneys General Practice Group, appeared on “LiveNOW” from FOX to explain that the defendant faces five federal charges, led by wire fraud, which carries a statutory maximum sentence of 20 years, along with charges for money laundering, commodities fraud, and misuse of nonpublic government information.
Benesch Partner Jonathan Todd Quoted in Law360 on Tariff Refund Litigation and Strategy
Jonathan Todd, vice chair of Benesch’s Transportation & Logistics Practice Group, was recently quoted in a Law360 article examining the complex legal battles emerging as companies, business partners, and consumers compete for refunds of $166 billion in tariffs invalidated by the U.S. Supreme Court, highlighting disputes over who is entitled to recover the money and how far litigation and regulatory scrutiny may extend.